Akèy › Kansè larinks › Illinois › Springfield
Etid klinik pou Kansè larinks nan Springfield, IL
3 etid pou Kansè larinks ap chèche patisipan nan sit nan ak bò kote Springfield (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Ap rekriteFaz 3
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Ap rekriteFaz 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Ap rekriteFaz 2
- Southern Illinois University School of Medicine, Springfield
- Springfield Clinic, Springfield
- Springfield Memorial Hospital, Springfield
Etid Kansè larinks nan lòt vil
- Chicago, IL8 etid
- Atlanta, GA8 etid
- Milwaukee, WI8 etid
- St. Louis, MO7 etid
- Kansas City, MO7 etid
- Edison, NJ6 etid
- Portland, OR6 etid
- Pittsburgh, PA6 etid
- Durham, NC6 etid
- Baltimore, MD6 etid
- Cincinnati, OH6 etid
- Richmond, VA6 etid
Lòt etid nan Springfield
- Kansè Poumon ki pa ti selil13 etid
- Kansè poumon12 etid
- Kansè kolorektal9 etid
- Leksemi mieloïd egi8 etid
- Kansè nan tete8 etid
- Karsinòm selil skuamèz tèt ak kou6 etid
- Kansè renn (Kasinom selil renn)6 etid
- Kansè pwostat6 etid
- Kansè (tout kalite)6 etid
- Kansè vejik6 etid
- Kansè pankreyas5 etid
- Melanom5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.